CLL Prognostication/Risk Stratification Gene Panel - EDTA Whole Blood
CLL Prognostication/Risk Stratification Gene Panel by NGS, EDTA Blood** Price
The CLL (Chronic Lymphocytic Leukemia) prognostication/risk stratification gene panel, performed on EDTA whole blood samples, is a diagnostic test used for assessing the prognosis and risk stratification of patients with CLL. This gene panel examines various genetic markers and mutations associated with CLL like TP53, NOTCH1, SF3B1, ATM, and other relevant genes. By analyzing these genetic markers, the panel helps in predicting disease progression, treatment response, and overall patient outcomes. The results of the panel aid healthcare professionals in determining the appropriate management strategies, including the selection of therapies and the frequency of follow-up evaluations. This CLL prognostication gene panel serves as a valuable tool in tailoring individualized treatment approaches and improving patient care for those diagnosed with CLL.
Frequently asked questions
Find quick answers to the most common questions about health tests, bookings, and reports.
Regular exercise, a balanced diet, avoiding smoking, maintaining a healthy weight, and managing stress all help reduce heart disease risk.
Common signs include irritability, trouble sleeping, headaches, difficulty concentrating, and muscle tension.
Ratings & Reviews
We're satisfying our customers every day since 1980.
Choose precision On time, every time!
- 98% on time collections with a 60 minutes promise
- Real-time tracking of phlebotomist arrival and report generation
- Fully digital report delivery—view from mobile or desktop instantly
- Continuous monitoring of turnaround times to ensure accuracy and speed
- Dedicated support team to resolve any delays or queries quickly
Why Metropolis Healthcare?
Metropolis has been present for over 40 years in the market.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
0
Years of experience
170+
Advanced Labs
Trusted by
Leading Doctors & Hospitals
2,000+
Scientific Officers
Proficiency Testing
for Accurate Reports
Latest Blogs & News
Stay informed with our expert insights and updates.
About Us
Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.
In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.